Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 22.
Patient Portal Technologies, Inc. Announces Third Quarter 2009 Financial Results
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BALDWINSVILLE, N.Y., Nov. 3, 2009 (GLOBE NEWSWIRE) -- Patient Portal Technologies, Inc. (OTCBB:PPRG) (Patient Portal) announced today financial results for the quarter and nine month period ended September 30, 2009.
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
Hoyer Criticizes GOP Health ProposalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
House Majority Leader Steny Hoyer criticized details of an alternate House Republican health-care plan, saying it would do little to extend insurance to those who don't have it.
Source: WSJ.com: Health - November 3, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Bill Trombetta 2009 Industry Audit (Part 3)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Good management is a mainstay for success regardless of whether a company is big or small. In this episode, Trombetta describes his metrics-driven approach to evaluating internal management strategies and highlights best practices from individual companies.
Source: Pharm Exec Podcast Interviews - November 3, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts
Health Sciences Group, Inc. Locks in Consulting Agreement With Medical Marijuana, Inc.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
INDIAN HARBOUR BEACH, Fla., Nov. 3, 2009 (GLOBE NEWSWIRE) -- Health Sciences Group, Inc. (Pink Sheets:HESG) is proud to announce that its CEO Thomas Gaffney has finalized a consulting agreement with Medical Marijuana, Inc. (Pink Sheets:MJNA) on a comprehensive agreement to advise on compliance issues with any state, local and city medical marijuana issues concerning the operations of dispensaries in California.
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
First Device Designed to Preserve Blood Flow to Iliac Arteries During Aneurysm Repair Receives Approval from Health CanadaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Minimally Invasive Treatment for Aortic Disease Is Safe, Effective Alternative to Open Surgery
BLOOMINGTON, Ind.--(HSMN NewsFeed)--Canadian physicians can now treat patients suffering from life-threatening aneurysms in one of the bodys largest arteries... Devices, Interventional, RegulatoryCook Medical, Endovascular Graft, abdominal aortic aneurysm, iliac artery
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
Alnara Pharmaceuticals Announces Appointment of Lee R. Brettman, M.D., FACP, to Chief Medical OfficerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CAMBRIDGE, Mass.--(HSMN NewsFeed)--Alnara Pharmaceuticals, a pharmaceutical company developing novel, non-systemic orally delivered protein therapeutics for the treatment of metabolic diseases, today announced the appointment of Lee R. Brettman, M.D., FACP... Biopharmaceuticals, PersonnelAlnara Pharmaceuticals
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
J&J to Slash Global Work ForceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Johnson & Johnson announced plans to lay off as many as 8,400 employees -- 7% of its global work force -- as part of a move to save as much as $1.7 billion in 2011.
Source: WSJ.com: Health - November 3, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Johnson and Johnson Announces Restructuring Initiatives for Sustainable GrowthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Continues to Invest in Promising Growth Opportunities
Identifies Projected, Annualized, Pre-Tax Cost Savings of $1.4-$1.7 billion
Expects to Take Associated Pre-Tax, Restructuring Charge of $1.1-$1.3 billion in Fourth Quarter of 2009
Confirms Earn... Biopharmaceuticals, DevicesJohnson & Johnson
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
Ingen CEO Live Radio Interview Friday With The Money ChannelEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
YUCAIPA, Calif., Nov. 3, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that the CEO, Scott Sand, will discuss the projected export sales of their new Oxyview Nasal Cannula this Friday, November 6, 2009 at 10:34AM Eastern Standard Time on The Money Channel's American Scene Radio with host Steve Crowley.
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
J&J to Slash Global Work ForceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Johnson & Johnson announced plans to lay off as many as 8,400 employees -- 7% of its global work force -- as part of a move to save as much as $1.7 billion in 2011.
Source: WSJ.com: Health - November 3, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C Virus Infection, at Liver Meeting 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
- IMO-2125 Induces Endogenous Interferons and Other Antiviral
Proteins -
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 3, 2009 - Idera
Pharmaceuticals, Inc. (Nasdaq: IDRA) today presents preclinical
data on the mechanism by which IMO-2125 was shown...
Source: Drugs.com - Clinical Trials - November 3, 2009 Category: Pharmaceuticals Source Type: clinical trials
DENTSPLY International Inc. to Present at Upcoming Credit Suisse Healthcare ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
YORK, Pa., Nov. 3, 2009 (GLOBE NEWSWIRE) -- DENTSPLY International Inc. (Nasdaq:XRAY) today announced that Bill Jellison, Sr. Vice President and Chief Financial Officer, will be presenting at Credit Suisse's 18th Annual Healthcare Conference in Phoenix, Arizona on November 12, 2009. Mr. Jellison's presentation will be at 10:30 AM (Mountain Standard Time). Conference presentations will not be webcasted.
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
SmallCapSentinel.com: Records and RevenuesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LAS VEGAS, Nov. 3, 2009 (GLOBE NEWSWIRE) -- According to news this morning by Metiscan, Inc. (Pink Sheets:MTIZ), a holding company focused on growing its organization by making key acquisitions and developing companies and emerging technologies, patients could soon be given the opportunity to review their personal diagnostic imaging reports online. Metiscan's wholly owned subsidiary, FirstView EHR, has entered into a partnership with The Estate Vault to use its comprehensive electronic online repository for consolidating and protecting medical, personal, financial, and legal records.
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
Lab to enterprise solutionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Union Department of Science and Technology (DST) has embarked on several projects that are meant to go beyond social relevance.
Source: The Economic Times Healthcare and Biotech News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Connecticut Attorney General Writes Seasonal Flu Vaccine Makers, Distributors Regarding Alleged Price Gouging, Preferential TreatmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HARTFORD, Conn. November 2, 2009 -Attorney
General Richard Blumenthal has written 13 makers and distributors
of scarce seasonal flu vaccine regarding allegations under
investigation by his office of price fixing and preferential
treatment for big...
Source: Drugs.com - Pharma News - November 3, 2009 Category: Pharmaceuticals Source Type: news
J&J to Cut as Much as 7% of Work ForceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Johnson & Johnson announced plans to lay off as many as 8,400 employees—7% of its global work force—as part of a move to save as much as $1.7 billion in 2011.
Source: WSJ.com: Health - November 3, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Miniature Microscope Can Improve Disease Detection, Diagnosis and TreatmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CHICAGO, Nov. 3, 2009 (GLOBE NEWSWIRE) -- New imaging technology using one of the world's smallest flexible microscopes enables physicians to look -- at the cellular level -- at living, moving tissue in the lungs and gastrointestinal tract so they can make a rapid diagnosis or carefully select tissue for biopsy.
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
Vivus promotes COO to presidentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Vivus Inc. promoted Peter Tam, its chief operating officer, to president. (XOMA) (VVUS)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 3, 2009 Category: Pharmaceuticals Source Type: journals
Advanced Medical Isotope Corporation Receives Positive Results from Initial Tests of a Proprietary and Innovative Method for the Domestic Production of Molybdenum-99Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
KENNEWICK, Wash., Nov. 3, 2009 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (Pinks Sheets:ADMD) (www.isotopeworld.com), a company engaged in the production and distribution of medical isotopes, is delighted to announce the encouraging results from initial tests conducted at Idaho State University (Pocatello, Idaho) in conjunction with researchers from the University of Missouri (Columbia, Missouri).
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
Rigel reports $26.7M loss in Q3Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In the third quarter ended September, Rigel Pharmaceuticals Inc. lost $26.7 million, down from a loss of $37.7 million in the same quarter a year earlier. (RIGL)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 3, 2009 Category: Pharmaceuticals Source Type: journals
NanoLogix Inc.: NanoLogix Files International Patent Applications, Reclaims 18 Existing Patents, Noted in Department of Defense Quarterly Publication and Provides Operations UpdateEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HUBBARD, OH (MARKET WIRE) NanoLogix, Inc. (PINKSHEETS: NNLX) announces that the company has recently filed BNP™ (BioNanoPore) national patent applications in China, Japan, India, Brazil, Russia and the EU. These applications were filed in order to obtain intellectual property protection for the company's technology in countries viewed as representing the largest potential international market for BNP rapid detection, a revolutionary sandwiched-membrane Petri-based technology that can reduce microorganism detection times by 100-400%.
Source: Market Wire - Pharmaceuticals and Biotech - November 3, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare NNLX Source Type: news
Brookdale curbs losses in 3QEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Brookdale Senior Living Inc. reported a loss in the third quarter, but still showed improvement over the same period last year. (BKD)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 3, 2009 Category: Pharmaceuticals Source Type: journals
N.C. workers’ comp premiums to drop 9.6%Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Businesses in North Carolina will pay less for workers’ compensation insurance next year, according to the N.C. Department of Insurance.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 3, 2009 Category: Pharmaceuticals Source Type: journals
Ambrilia Biopharma Inc.: Ambrilia Biopharma Provides Bi-Weekly Status UpdateEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MONTREAL, QUEBEC (MARKET WIRE) Ambrilia Biopharma Inc. (TSX: AMB) is providing today its bi-weekly Default Status Report under National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("Default Status Report").
Source: Market Wire - Pharmaceuticals and Biotech - November 3, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech AMB Source Type: news
Cutting Edge Information: Pharmaceutical Speaker Programs an Important Source of Medical Education, Says Cutting Edge InformationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
RESEARCH TRIANGLE PARK, NC (MARKET WIRE) Like many other marketing activities within the industry, pharmaceutical speaker programs -- and the physician-industry relationships that they consist of -- are under attack, most recently by the Boston Globe.
Source: Market Wire - Pharmaceuticals and Biotech - November 3, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news
J&J to Cut Up to 7% of Work ForceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Johnson & Johnson announced plans to lay off as many as 8,400 employees worldwide -- 7%of its work force -- as part of a move to save up to $1.7 billion in 2011.
Source: WSJ.com: Health - November 3, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
IPOdesktop.com Internet Radio Series Interviews Orthopedic Surgeon Dr. Eugene Wolf, Who Sees Multiple Applications in His Specialty for BioSpecifics' XIAFLEX(TM)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LYNBROOK, N.Y., Nov. 3, 2009 (GLOBE NEWSWIRE) -- IPOdesktop.com, in a continuation of its Internet radio interviews featuring BioSpecifics Technologies Corp. (Nasdaq:BSTC), today features an interview with Dr. Eugene Wolf. Dr. Wolf is based in San Francisco, and is a board certified orthopedic surgeon who has practiced in the Bay area for the past 30 years. In the interview, Dr. Wolf says that XIAFLEX may have broad applications within his area of specialization, particularly in frozen shoulder and knee surgery, where XIAFLEX has the potential to shorten the entire healing process.
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
Johnson & Johnson Announces Restructuring Initiatives for Sustainable GrowthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Continues to Invest in Promising Growth Opportunities
Identifies Projected, Annualized, Pre-Tax Cost Savings of $1.4-$1.7
billion Expects to Take Associated Pre-Tax, Restructuring Charge of
$1.1-$1.3 billion in Fourth Quarter of 2009 Confirms...
Source: Drugs.com - Pharma News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Quintiles Announces Clinical Pharmacology Alliance With AstraZenecaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Quintiles today announced that it has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca's clinical pharmacology studies across multiple therapy areas and around the globe.
Source: Pharmaceutical Online News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Viking Systems, Inc. Reports Third Quarter Results; Provides Business UpdatesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WESTBOROUGH, Mass., Nov. 3, 2009 (GLOBE NEWSWIRE) -- Viking Systems, Inc. (OTCBB:VKNG), a supplier of 2D and 3D visualization systems for the medical market, today announced results for the quarter ended September 30, 2009. The Company reported that it has made significant progress in its objective to reach sustainable positive cash flow from operations and that it is exploring strategic and financing options in order to fund anticipated 2010 operating losses while the Company develops and launches its "Next Generation" 3DHD Visualization System. Additionally, the Company discussed a significant order for its current 3Di s...
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
K2M Enters Japanese Spine MarketEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MESA Spinal System Clearance Enables Sale and Distribution in Japan
LEESBURG, Va., Nov. 3--(HSMN NewsFeed)--K2M, Inc., the spinal device company developing innovative and simplified solutions for the treatment of complex spinal pathologies and procedure... Devices, Orthopaedic, NeurosurgeryK2M, MESA Spinal System, spine surgery
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
Study Finds Lack of Diffusible VEGF Growth Factor Can Cause Retinal Defects Similar to Dry Macular DegenerationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Discovery may also have impact on the use of new drugs for
wet macular degeneration
BOSTON, Nov. 2 /PRNewswire-USNewswire/ -- Scientists at Schepens
Eye Research Institute have found that when the eye is missing a
diffusible form of vascular...
Source: Drugs.com - Clinical Trials - November 3, 2009 Category: Pharmaceuticals Source Type: clinical trials
Sanofi Pasteur Presents Safety Data on Menactra Vaccine Given to Infants at Infectious Disease Society MeetingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The two-dose meningococcal quadrivalent conjugate vaccine was
generally well-tolerated
PHILADELPHIA, Nov. 2 /PRNewswire/ -- Sanofi Pasteur, the
vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE:
SNY), presented Safety of a...
Source: Drugs.com - Clinical Trials - November 3, 2009 Category: Pharmaceuticals Source Type: clinical trials
LDR's VerteBRIDGE Plating Technology Reaches New MilestoneEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AUSTIN, Texas, Nov 3--(HSMN NewsFeed)--LDR, a total spine solution company, announced today that since product launch 18 months ago there have been more than 3,000 devices with VerteBRIDGE plating technology implanted worldwide. Over 2,500 of these device... Devices, Orthopaedic, NeurosurgeryLDR Spine, VerteBRIDGE, ROI-A, ROI-C, spine surgery
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
29.10.09: Bonds: EMTN ProgramEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Bonds: EMTN ProgramNew: Supplement dated October 28, 2009 Link to websiteAll changes
Source: Bayer IR Newsfeed: New on this site - November 3, 2009 Category: Pharmaceuticals Source Type: news
ZEVALIN® Receives Positive Reimbursement Ruling Using Average Sales Price (ASP) MethodologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ZEVALIN Was Recently Approved by the FDA for the Treatment Of Patients With Previously Untreated Follicular Non-Hodgkins Lymphoma (NHL), Who Achieve A Partial Or Complete Response To First-Line Chemotherapy
IRVINE, Calif., Nov 3--(HSMN NewsFeed)--Spect... Biopharmaceuticals, Oncology, ReimbursementSpectrum Pharmaceuticals, ZEVALIN, ibritumomab tiuxetan, non-Hodgkins Lymphoma
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
ZEVALIN(R) Receives Positive Reimbursement Ruling Using Average Sales Price (ASP) MethodologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ZEVALIN Was Recently Approved by the FDA for the Treatment Of Patients With Previously Untreated Follicular Non-Hodgkins Lymphoma (NHL), Who Achieve A Partial Or Complete Response To First-Line Chemotherapy
IRVINE, Calif., Nov 3--(HSMN NewsFeed)--Spect... Biopharmaceuticals, Oncology, ReimbursementSpectrum Pharmaceuticals, ZEVALIN, ibritumomab tiuxetan, non-Hodgkins Lymphoma
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer's DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pfizer Inc and Medivation, Inc. recently announced the initiation of CONTACT and CONSTELLATION, two Phase 3 trials of the investigational drug dimebon (latrepirdine)* in patients with moderate-to-severe Alzheimer's disease (AD).
Source: Pharmaceutical Online News - November 3, 2009 Category: Pharmaceuticals Source Type: news
VIVUS Announces Promotion of Peter Tam to PresidentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Tam Also Appointed to VIVUS Board of Directors
MOUNTAIN VIEW, Calif., Nov. 3 (HSMN NewsFeed) -- VIVUS, Inc. (Nasdaq: VVUS ) today announced the promotion of Peter Tam to president of VIVUS. In this position, Mr. Tam will lead and have overall responsi... Biopharmaceuticals, PersonnelVIVUS
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
Symphogen Opens US Operations in Princeton, New JerseyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
US Subsidiary Supports Expanding Opportunities for Symphogens Novel Antibody Pipeline and Discovery and Expression Platforms
COPENHAGEN & PRINCETON, N.J., Nov 3--(HSMN NewsFeed)--Symphogen A/S today announced the opening of its United States headquarte... BiopharmaceuticalsSymphogen
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
Johnson & Johnson Announces Restructuring Initiatives for Sustainable Growth
(Nov 3, 2009)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New Brunswick, NJ (Nov. 3, 2009) – Johnson & Johnson today announced global restructuring initiatives designed to strengthen the company’s position as the world’s leading global health care company. The company is taking steps to prioritize its innovation efforts around the many growth opportunities in health care and to execute aggressively on bringing key new products to market. .....
Source: Johnson and Johnson - November 3, 2009 Category: Pharmaceuticals Source Type: organizations
LHC Group and Twin Lakes Regional Medical Center Announce Home Health Joint VentureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LAFAYETTE, La., Nov. 3, 2009 (GLOBE NEWSWIRE) -- LHC Group, Inc. (Nasdaq:LHCG), one of the largest providers of home health services in the United States, announced today that it has entered into a home health joint venture with Twin Lakes Regional Medical Center in Leitchfield, Kentucky.
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
Trading Outlook for Illumina Inc. Issued by StockPreacher.comEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DALLAS, Nov. 3, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Illumina Inc. (Nasdaq:ILMN). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
Heart Valve for Boy With Swine FluEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Doctors at Children's Hospital Boston successfully implanted an experimental heart valve in a boy with a congenital heart defect to relieve potentially fatal complications caused by swine flu.
Source: WSJ.com: Health - November 3, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Leading Scientists To Present Work On Powder Flow Measurement And Understanding At One-Day Conference In LondonEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Practice, Theory, Visualisation and Meaning is a one-day conference organised by The Formulation Group of the Royal Society of Chemistry (RSC) in partnership with Freeman Technology and in association with Dechema.
Source: Pharmaceutical Online News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Matsyafed sniffs new biz in nutraceutical domainEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Matsyafed has been engaged in the implementation of a broad range of welfare schemes for the fishing community, with the objective of ensuring their socio-economic uplift.
Source: The Economic Times Healthcare and Biotech News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Accentia to tap European marketEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Healthcare receivables cycle management major Accentia Technologies based at the Technopark here has commenced operations from the UK, with the objective of tapping potential markets in Northern Ireland, England and Scotland
Source: The Economic Times Healthcare and Biotech News - November 3, 2009 Category: Pharmaceuticals Source Type: news
